Table 3.
Unadjusted, raw means for ASI-3 and PDSS-SR at each time point beginning at randomization.
| ASI-3 | PDSS | |||
|---|---|---|---|---|
| DCS | PBO | DCS | PBO | |
| week | mean (SD) | mean (SD) | mean (SD) | mean (SD) |
| 3 | 22.63 (14.33) | 22.26 (13.68) | 8.63 (4.06) | 7.48 (5.93) |
| 4 | 20.88 (14.99) | 17.73 (11.18) | 7.29 (5.00) | 7.41 (4.96) |
| 5 | 20.80 (13.47) | 19.78 (14.04) | 6.55 (5.03) | 6.87 (6.38) |
| 6 | 17.00 (11.07) | 16.58 (13.27) | 5.79 (5.28) | 6.16 (6.40) |
| 7 | 15.37 (10.38) | 17.80 (13.77) | 5.32 (5.14) | 6.65 (6.91) |
| 9 | 16.00 (10.71) | 15.32 (13.21) | 4.56 (4.90) | 5.89 (5.83) |
| 13 | 16.64 (8.87) | 18.00 (13.99) | 6.82 (4.26) | 4.73 (6.35) |
| 15 | 14.45 (8.95) | 17.24 (14.03) | 5.55 (3.47) | 7.06 (6.51) |
| 21 | 17.00 (10.06) | 16.15 (11.17) | 5.80 (4.66) | 6.23 (7.42) |
| 29 | 16.43 (11.01) | 17.89 (14.43) | 5.36 (6.96) | 5.40 (5.93) |
Note: When ASI-3 and PDSS were assessed at a treatment session (weeks 3–7), the assessment took place at the beginning of the session.